Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Butorphanol in perspective.

C E Rosow1

  • 1Department of Anesthesia, Harvard Medical School, Massachusetts General Hospital, Boston.

Acute Care
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Butorphanol tartrate, an opioid agonist-antagonist, effectively manages severe pain with a favorable safety profile. It offers limited respiratory depression and low abuse potential, making it a valuable analgesic option.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reversal of opioid-induced bladder dysfunction by intravenous naloxone and methylnaltrexone.

Clinical pharmacology and therapeutics·2007
Same author

Pharmacokinetics and pharmacodynamics of inhaled versus intravenous morphine in healthy volunteers.

Anesthesiology·2000
Same author

Pediatric evaluation of the bispectral index (BIS) monitor and correlation of BIS with end-tidal sevoflurane concentration in infants and children.

Anesthesia and analgesia·2000
Same author

The tumescent technique: the effect of high tissue pressure and dilute epinephrine on absorption of lidocaine.

Plastic and reconstructive surgery·1999
Same author

A randomized, double-blind, dose-response study of ondansetron in the prevention of postoperative nausea and vomiting.

Journal of clinical anesthesia·1998
Same author

Methylnaltrexone: reversing the gastrointestinal effects of opioids.

Anesthesiology·1997
Same journal

Influence of age on the pharmacokinetics of butorphanol.

Acute care·1988
Same journal

Outpatient sedation for oral surgery: a comparison of butorphanol and fentanyl.

Acute care·1988
Same journal

Double-blind comparison of butorphanol and morphine in patient-controlled analgesia.

Acute care·1988
Same journal

Patient-controlled analgesia using butorphanol for postoperative pain relief: an open-label study.

Acute care·1988
Same journal

Urological applications of butorphanol tartrate: postoperative pain and renal colic.

Acute care·1988
Same journal

Butorphanol tartrate: research advances in multiple clinical settings.

Acute care·1988
See all related articles

Area of Science:

  • Pharmacology
  • Anesthesiology
  • Pain Management

Background:

  • Opioid analgesics are crucial for pain management.
  • Opioid agonist-antagonists offer distinct receptor interactions compared to pure agonists.
  • Understanding the unique properties of butorphanol tartrate is essential for its clinical application.

Purpose of the Study:

  • To review the pharmacological and clinical profile of butorphanol tartrate.
  • To highlight its efficacy in pain relief and safety characteristics.
  • To compare its effects with pure opioid agonists.

Main Methods:

  • Review of existing clinical data and pharmacological studies on butorphanol tartrate.
  • Analysis of its receptor binding profile and clinical effects.

Related Experiment Videos

  • Evaluation of safety data, including side effects and potential for abuse.
  • Main Results:

    • Butorphanol tartrate demonstrates effective analgesia for severe pain.
    • It exhibits limited respiratory depression and smooth muscle spasm, reversible with naloxone.
    • Sedation is the most prominent side effect, often beneficial in the perioperative setting.
    • The drug has a low potential for abuse and toxicity.

    Conclusions:

    • Butorphanol tartrate is a safe and effective opioid agonist-antagonist analgesic.
    • Its unique receptor interactions contribute to its distinct clinical profile.
    • Clinical experience supports its utility, particularly in perioperative pain management due to its safety and low abuse potential.